A carregar...
Rituximab for autoimmune retinopathy: Results of a Phase I/II clinical trial
PURPOSE: This prospective study evaluates whether rituximab is a safe and potentially effective treatment for nonparaneoplastic autoimmune retinopathy (npAIR). MATERIALS AND METHODS: Five npAIR patients were enrolled in a Phase I/II, prospective, nonrandomized, open-label, single-center study. All p...
Na minha lista:
| Publicado no: | Taiwan J Ophthalmol |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Wolters Kluwer - Medknow
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7971443/ https://ncbi.nlm.nih.gov/pubmed/33767957 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/tjo.tjo_32_20 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|